Quality of life in children receiving treatment for Mycobacterium abscessus otomastoiditis.
- Resource Type
- Article
- Authors
- Leow, Theresa Y.S.; Bekkers, Stijn; Janssen, Arno M.; Pegge, Sjoert A.H.; Kunst, Henricus P.M.; Waterval, Jerome J.; Jansen, Thijs T.G.; Henriet, Stefanie S.V.; van Aerde, Koen J.; van Ingen, Jakko; Hol, Myrthe K.S.
- Source
- Clinical Otolaryngology. Jul2022, Vol. 47 Issue 4, p529-535. 7p.
- Subject
- *QUALITY of life
*MYCOBACTERIUM
*BURULI ulcer
*PERIPHERALLY inserted central catheters
*OTITIS media
- Language
- ISSN
- 1749-4478
Patients tested within 1 year after finishing treatment reported significantly lower COMBI scores than patients tested >1 year after starting/finishing antibiotic treatment (32.4 vs. 51.8; I p i < .001; 95% CI (-)25.6 - (-)13.1). Baseline illustrates a GCBI-score (=0) in which no change is perceive gl Patients who ended treatment less than 1 year ago had a lower mean GCBI-score compared to patients who finished treatment more than 1 year ago ((-)12.9 vs. + 10.9; I p i = .991; 95% CI (-)52.3 to 4.6 [Figure 2]). Keywords: children; Mycobacterium abscessus; otomastoiditis; quality of life EN children Mycobacterium abscessus otomastoiditis quality of life 529 535 7 06/14/22 20220701 NES 220701 Key points I Mycobacterium abscessus i is a multidrug-resistant nontuberculous mycobacterium capable of causing otomastoiditis and its treatment is complex with frequent adverse events. [Extracted from the article]